Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaoling Mao
Institutions:
Jiangxi Provincial Cancer Hospital,
Nanchang Medical College
Observed institutions:
Jiangxi University of Traditional Chinese Medicine,
Jiangxi Provincial Cancer Hospital,
Nanchang Medical College
ORCID:
0009-0001-1722-6415
Observed ORCID:
0009-0001-1722-6415
OpenAlex ID:
A5020717799
From tumor microenvironment to emerging biomarkers: the reshaping of the esophageal squamous cell carcinoma tumor microenvironment by neoadjuvant chemotherapy combined with immunotherapy
2024
·
Zhengzhou Qiu
, Zhao Li
, et al.
·
Frontiers in Immunology
·
13
PDF
Harmine inhibits ovarian cancer migration and invasion and epithelial-mesenchymal transition (EMT) by inhibiting HDAC7 to restore RECK expression
2025
·
Yin Bao
, Jun Zhu
, et al.
·
Biochemical Pharmacology
·
3
Pharmacological Mechanisms of Kirenol against Ovarian Carcinoma: A Network Pharmacology and Experimental Validation Study In Vitro
2024
·
Xiaoling Mao
, Hong Zhu
, et al.
·
Combinatorial Chemistry & High Throughput Screening
·
2
Yiyi Fuzi Baijiang formula protects against DSS-induced colitis by orchestrating the gut barrier-microbiota-metabolism axis
2026
·
Yin Bao
, Qiang Ao
, et al.
·
Chinese Medicine
Yiyi Fuzi Baijiang formula protects against DSS-induced colitis by orchestrating the gut barrier-microbiota-metabolism axis
2026
·
Yin Bao
, Qiang Ao
, et al.
·
Figshare
Show more works
View as search
Works count:
8
Citation count:
18
H-index:
2
I10-index:
1
Year
Topic
Type